PARLIAMENT'S last day of sitting for 2016 saw the first reading of the Therapeutic Goods Amendment (2016 Measures No 1) Bill 2016, introduced by Health Minister, Hon Sussan Ley.
Medicines Australia (MA) chief executive Milton Catelin said the Bill supported new regulation-making powers that would create two new pathways to help speed up approval of medicines.
"For a number of years, Medicines Australia and member companies have worked with the Australian Government to identify improvements in our registration approval processes, and related matters," Catelin said.
"The Bill addresses these concerns head-on.
"The changes to approval, registration and listing times mean that Australian patients will get faster access to safe medicines.
"The measures have widespread cross-political support and we expect it to pass without delay in 2017 as this is in the best interests of the Australian people.
"We will continue to work with the Therapeutic Goods Administration to ensure we all get the detailed regulations right".
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Dec 16
